195 Pt NMR parameters as strong descriptors in one-parameter QSAR models for platinum-based antitumor compounds

Copyright © 2016 John Wiley & Sons, Ltd.

Bibliographische Detailangaben
Veröffentlicht in:Magnetic resonance in chemistry : MRC. - 1985. - 55(2017), 7 vom: 01. Juli, Seite 662-669
1. Verfasser: Tsipis, Athanassios C (VerfasserIn)
Weitere Verfasser: Karapetsas, Ioannis N
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2017
Zugriff auf das übergeordnete Werk:Magnetic resonance in chemistry : MRC
Schlagworte:Journal Article 195Pt NMR 195Pt NMR descriptors Pt-based anticancer drugs QSAR model homogeneous series of Pt-based drugs photoactivable Pt(IV) complexes Antineoplastic Agents Coordination Complexes Solvents mehr... Platinum 49DFR088MY
LEADER 01000naa a22002652 4500
001 NLM267360673
003 DE-627
005 20231224220520.0
007 cr uuu---uuuuu
008 231224s2017 xx |||||o 00| ||eng c
024 7 |a 10.1002/mrc.4570  |2 doi 
028 5 2 |a pubmed24n0891.xml 
035 |a (DE-627)NLM267360673 
035 |a (NLM)28002879 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Tsipis, Athanassios C  |e verfasserin  |4 aut 
245 1 0 |a 195 Pt NMR parameters as strong descriptors in one-parameter QSAR models for platinum-based antitumor compounds 
264 1 |c 2017 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 26.04.2018 
500 |a Date Revised 26.04.2018 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Copyright © 2016 John Wiley & Sons, Ltd. 
520 |a Highly predictive one-parameter quantitative structure-activity relationship models have been developed for platinum-based anticancer drugs using the 195 Pt NMR parameters as strong descriptors. The developed quantitative structure-activity relationship models were applied in diverse homogeneous sets of antiproliferative Pt(II) and Pt(IV) compounds. These observations form the basis for making predictions of cytotoxicity for a broad range of platinum-based antitumor compounds just from inspection of calculated or experimentally determined 195 Pt NMR parameters. Copyright © 2016 John Wiley & Sons, Ltd 
650 4 |a Journal Article 
650 4 |a 195Pt NMR 
650 4 |a 195Pt NMR descriptors 
650 4 |a Pt-based anticancer drugs 
650 4 |a QSAR model 
650 4 |a homogeneous series of Pt-based drugs 
650 4 |a photoactivable Pt(IV) complexes 
650 7 |a Antineoplastic Agents  |2 NLM 
650 7 |a Coordination Complexes  |2 NLM 
650 7 |a Solvents  |2 NLM 
650 7 |a Platinum  |2 NLM 
650 7 |a 49DFR088MY  |2 NLM 
700 1 |a Karapetsas, Ioannis N  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Magnetic resonance in chemistry : MRC  |d 1985  |g 55(2017), 7 vom: 01. Juli, Seite 662-669  |w (DE-627)NLM098179667  |x 1097-458X  |7 nnns 
773 1 8 |g volume:55  |g year:2017  |g number:7  |g day:01  |g month:07  |g pages:662-669 
856 4 0 |u http://dx.doi.org/10.1002/mrc.4570  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 55  |j 2017  |e 7  |b 01  |c 07  |h 662-669